Neurosurgery to restore function in cerebral palsy: current practice and emerging therapies.
Akshay Sankar, Awa Jobe, Bailey McDonald and 3 others
PMID 42063808WHAT IT FOUND
This review maps neurosurgical options for cerebral palsy movement disorders.
It notes SDR helps spasticity but can unmask dystonia, while DBS and spinal cord stimulation remain investigational for children. Outcomes vary by phenotype, requiring individualized selection and intensive rehab.
Key findings
01Selective dorsal rhizotomy reduces spasticity and may improve gross motor function, but it is primarily for lower limbs and can unmask underlying dystonia.
02Deep brain stimulation and spinal cord stimulation show promise for dystonia and spasticity, but data are mixed, largely off-label for children, and require further trials.
03Intrathecal baclofen effectively manages severe spasticity and dystonia but carries high complication rates, including infection and potential scoliosis progression.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The review is narrative and does not perform a new systematic search or meta-analysis. Evidence for many interventions, such as spinal cord stimulation and focused ultrasound, is based on small studies, case series, or pilot trials with low quality of evidence. Long-term outcomes and comparative effectiveness between different surgical options are not well-established. The review does not provide new patient-level data.
Declared interests
The authors declared financial support for the work. Research was supported by the Dystonia Medical Research Foundation.
The easy way to misread this
Do not interpret this review as evidence that neurosurgery restores function in all cerebral palsy cases. Many interventions are investigational or off-label for children, and outcomes are highly variable depending on the specific movement disorder phenotype.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →